Diagnostic Solutions for Pharma {{searchText ? ' for "' : ''}}{{searchText}}{{searchText ? '"' : ''}}

The GeneXpert® system from Cepheid enables standardized, central-lab quality molecular diagnostic testing at the point-of-care to:

  • Accelerate clinical trial enrollment by brining the test to trial sites
  • Reach diverse populations through a point-of-need test-and-treat program
  • Improve accessibility of companion and complementary diagnostics

Cepheid has Partnered with Pharma to Support Clinical Trials Worldwide for over a decade(1)

The Preferred Simple, and Real-time Diagnostic Solution for Clinical Trials

The GeneXpert system is a point-of-care molecular diagnostic solution, automating the complex, manual steps of polymerase chain reaction (PCR), while combining fast turnaround times with simple workflows for real-time PCR results.

 

Improve Patient Outcomes with a Test-and-Treat Program

Xpert® tests provide medically actionable information for patients to receive same-day treatment

The Xpert Cartridge

Sample extraction, PCR amplification, and detection are all carried out within this lab in a cartridgeTM

All Xpert tests can run on any GeneXpert system, providing random access to 2-80 tests simultaneously–no need for batching.

Comprehensive PCR Menu

The GeneXpert® family of systems can run any of Cepheid's 34 CE-IVD and 22 US-IVD tests to provide accurate, high-quality, real-time PCR results.

GeneXpert Family of Systems

Available in two, four, 16, 48, or 80-module configurations, the GeneXpert platform is both standardized and scalable across the clinical trial continuum — from central labs to remote trial sites to mobile testing.

US-IVD. In Vitro Diagnostic Medical Device.

1. PR Newswire. Cepheid Collaborates With Pharmaceutical Leader on Chronic Myelogenous Leukemia. Accessed Oct. 12, 2022. http://cepheid.mediaroom.com/2010-10-07-Cepheid-Collaborates-With-Pharmaceutical-Leader-on-Chronic-Myelogenous-Leukemia